Secondly, this study identified NIPAL1,PARP10, and ZYG11B as potential prognostic biomarkers for CRC through multi-omicsanalysis, but further experimental validation is needed to elucidate the specificfunctional roles of these genes in CRC progression. This evidence concerns the gene PARP10 and colorectal carcinoma.